Regeneron’s Veopoz scores FDA approval for rare immune disease
Regeneron Pharmaceuticals has received US Food and Drug Administration (FDA) approvals for two of its drugs, namely Veopoz (pozelimab-bbfg) and…
Regeneron Pharmaceuticals has received US Food and Drug Administration (FDA) approvals for two of its drugs, namely Veopoz (pozelimab-bbfg) and…
Pfizer’s Elrexfio (elranatamab-bcmm) has received accelerated approval from the US Food and Drug Administration (FDA) to treat adults with relapsed…